Cargando…
Peer Review of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414311/ http://dx.doi.org/10.2196/33499 |
Ejemplares similares
-
Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”
por: Jarrett, Mark, et al.
Publicado: (2021) -
Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study
por: Jarrett, Mark, et al.
Publicado: (2021) -
Peer reviewers
por: Wauson, Stephanie D.
Publicado: (2021) -
Peer Review of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
por: Roy, Archisman
Publicado: (2021) -
Peer Review of “Utility of the ROX Index in Predicting Intubation for Patients With COVID-19–Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study”
por: Sehgal, Mukul
Publicado: (2021)